Column Group LLC Long-Term Concentrated

CIK: 0001833486 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value ($000): $451,820 (100.0% shares, 0.0% debt)

Holdings (7)

— NGM Biopharmaceuticals Inc 52.5%

Value ($000) $237,228 Shares 18,136,735 Est. Cost $27.77 Unrealized —

RVMD Revolution Medicines Inc 20.0%

Value ($000) $90,275 Shares 4,577,840 Est. Cost $34.24 Unrealized -35.8%

— RAPT Therapeutics Inc 14.3%

Value ($000) $64,492 Shares 2,680,458 Est. Cost $19.03 Unrealized —

TNYA Tenaya Therapeutics, Inc. 6.0%

Value ($000) $27,261 Shares 9,400,290 Est. Cost $21.49 Unrealized -78.3%

— Surrozen, Inc. 4.1%

Value ($000) $18,681 Shares 9,248,129 Est. Cost $7.07 Unrealized —

ORIC ORIC Pharmaceuticals Inc. 2.5%

Value ($000) $11,418 Shares 3,568,181 Est. Cost $28.69 Unrealized -86.0%

— eFFECTOR Therapeutics Inc 0.5%

Value ($000) $2,465 Shares 4,309,329 Est. Cost $14.05 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	NGM Biopharmaceuticals Inc	18,136,735	$237,228	52.5%	$27.77	—	COM	62921N105
RVMD	Revolution Medicines Inc	4,577,840	$90,275	20.0%	$34.24	-35.8%	COM	76155X100
—	RAPT Therapeutics Inc	2,680,458	$64,492	14.3%	$19.03	—	COM	75382E109
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$27,261	6.0%	$21.49	-78.3%	COM	87990A106
—	Surrozen, Inc.	9,248,129	$18,681	4.1%	$7.07	—	COM	86889P109
ORIC	ORIC Pharmaceuticals Inc.	3,568,181	$11,418	2.5%	$28.69	-86.0%	COM	68622P109
—	eFFECTOR Therapeutics Inc	4,309,329	$2,465	0.5%	$14.05	—	COM	28202V108